Click on the button under the session details to view the agenda.

Monday

Advancing person-centred care across the cardiometabolic spectrum through scientific innovation

Changing the Course of Cardiometabolic Disease

Next-gen diabetes care: The evolving place of basal insulin therapy with technology and AI

Pushing the Limits of What Sensing Can Do for T1D and T2D

A Patient-Centered Approach to Long-Term Obesity Management

Unlocking scalable T1D Autoantibody Testing in Clinical Care

From Sensors to Integrated Care: Emerging Technologies Shaping the Future of Diabetes Management

Live From The Newsroom: Obesity Uncovered

Making the connections to reduce risk: cardiovascular, renal and metabolic benefits of SGLT2 inhibitors in T2D

A new era in autoimmune T1D: Translating emerging potential into clinical reality with teplizumab

Non-steroidal MRA – Expanding Cardiorenal Care in Diabetes and Beyond

Rewiring Metabolic Disease: The role of GLP-1 and glucagon physiology in glucose handling, weight control, CKD and MASH

Beyond weight loss: A biology-driven approach to metabolic health

From Headlines to Practice: A Live Podcast on the Future of Obesity Care

Injection Technique in Endocrine Therapy: Addressing Lipohypertrophy and Enhancing Outcomes Across Insulin and GLP-1 Injectables

Reducing acute pancreatitis through apoC-III inhibition in people with severe hypertriglyceridemia

Improving Heart, Kidney and Liver Health in People with Diabetes: A Patient-Based Approach

Tuesday

Fat where we don’t want it: The fundamental role of visceral and ectopic fat in type 2 diabetes

A commitment to change: Integrating environmental responsibility in diabetes care

Making change happen: Building, implementing and advancing early-stage T1D pathways

Rethinking Diabetes Diagnosis Targets: How CGM Can Inform Risk, Progression, Monitoring and Earlier Decision Making

Essence of MASH management: practical strategies to improve patient outcomes in diabetes clinics

One technology, many realities: The real-world value of (predictive) CGM across the diabetes spectrum

Early combination therapy in type 2 diabetes: harmonizing glycemic control and cardiorenal protection.

The Early-stage T1D Care Pathway: Practical and Real-world Experience

The earlier, the longer, the better in Diabetes management

Semaglutide in obesity care: comprehensive evidence and emerging science

The Next Revolution in Diabetes Care: From Glucose Monitoring to Dual Sensing

Wednesday

Metformin for Early Birds: Quick-start Strategies to delay Diabetes and its Burdens

At the Cutting Edge of Automated Insulin Delivery: CamAPS Liberty, Pregnancy and the Menstrual Cycle

Did you sleep well? How predictive CGM technology transforms nocturnal hypoglycaemia management

From Evidence to Standard of Care: CGM Beyond MDI in Every Type 2 Diabetes Care Plan

A new era in autoimmune T1D: Navigating the realities of teplizumab treatment

Scaling CGM Across Care: RCT Results of CGM in Non-Insulin Treated Type 2 Diabetes and Population-Health Pathways

BR1DGE Talk: Practical Guidance on Optimizing the Sustainability and Cost Effectiveness of T1D Screening

Early Intervention, Lasting Benefit: Reshaping the Obesity Treatment Paradigm

A New Direction in T1D? Redefining Success From Survival to Freedom

Muscle Health in Diabetes: A New Lever to Improve Glycemic Control and Patient Outcomes

Liver-Directed Approach to Moderate to Advanced MASH: Implications for Diabetes Specialists

Advancing the amylin story: from scientific rationale to future cardiometabolic care

Insulin efsitora alfa in type 2 diabetes: The evolution of basal insulin from daily to once-weekly formulations

Thursday

Let’s talk amylin: the next wave in metabolic and obesity care

Turn Up the Volume or Fine-Tune the Balance? Debating GDMT for cardio-kidney protection

Exploring the power of predictive CGM: Insights on performance, psychology, and the perspective of people living with diabetes

Strong Results. True Simplicity. Is Omnipod® 5 Changing The Trade-Off?

Introducing Libre Duo: A New Era in Diabetes Sensing Technology

Reshaping MDI therapy with MiniMed™ Go

Changing the trajectory of chronic metabolic disease: the evolving role of GLP-1-based care

Friday

Advancing Clinical Practice With CGM: Evidence, Education, and System Level Implementation

Facts vs Myths in AID therapy

Dexcom Technology and Clinical Implications: Driving Innovation That Meets HCP and Patient Needs